UPDATE
: Monday, September 7, 2020
Home
Login
Mobile Version
All
Hospital
Pharma
Bio
Korea‘s Bio Industry
Device/ICT
Policy
People
Life science
Special
Innovation for Survival
Korea’s medical culture series
Korea’s New Candidate Drug Watch List
Special Series in Celebration of KBR's 1st Anniversary
Interview with foreign envoys
Special Series in Celebration of KBR’s 2nd Anniversary
Interview with global pharma
Special Series in Celebration of KBR’s 3rd Anniversary
Special Series in Celebration of KBR’s 4th Anniversary
ASCO 2020 Highlights
Opinion
Reporter’s Notebook
Search
트위터
페이스북
RSS
상단여백
제목보기
제목보기
제목+내용
Samsung BioLogics wins FDA nod for drug manufacturing procedure
Samsung BioLogics said Thursday that it has received approval for a drug su...
by Lee Han-soo
|
2018-05-24 15:56
라인
7 Korean biopharma firms dive into biosimilar market
Korea’s “bio fever” is being spurred on by the domestic development of bios...
by Marian Chu
|
2018-05-19 08:19
라인
Celltrion posts ₩245 billion in Q1 sales thanks to biosimilar uptake
Celltrion recorded sales of 245 billion won ($227 million) in the first qua...
by Marian Chu
|
2018-05-16 12:13
라인
Will Korean bio stocks rebound as MSCI includes Celltrion, Viromed, HLB?
Although the stocks of Korean biopharmaceutical companies plummeted followi...
by Marian Chu
|
2018-05-16 11:25
라인
Korean biosimilar companies welcome US pro-biosimilar initiative
Korean biosimilar companies, such as Celltrion welcomed U.S. President Dona...
by Lee Han-soo
|
2018-05-15 17:07
라인
Biotech shares weaken on KONEX, too
As biotech stocks on KOSPI and KOSDAQ have turned downward since mid-April,...
by Nam Doo-hyun
|
2018-05-15 14:02
라인
Large pool of capital available in biotech space: US venture fund expert
American venture capital firms like Mountain Pacific have raised a record a...
by Marian Chu
|
2018-05-11 18:10
라인
HAFS students win grand prize in KHIDI Bio Startup Contest
Three students from Hankuk Academy of Foreign Studies took the grand prize ...
by Marian Chu
|
2018-05-11 14:32
라인
Samsung BioLogics shares recover despite window dressing controversy
Biotech and pharmaceutical shares are bouncing back from recent massive sli...
by Nam Doo-hyun
|
2018-05-10 11:08
라인
Bio & Medical Korea 2018 kicks off
Bio Korea 2018 and Medical Korea 2018 kicked off for a three-day run in COE...
by Lee Han-soo
|
2018-05-09 11:55
라인
Va-Q-Tec to up investment in Korean biopharmaceuticals
Germany’s logistics and packaging company Va-Q-Tec said it would significan...
by Nam Doo-hyun
|
2018-05-09 11:54
라인
Pharma, biotech shares tank amid Samsung BioLogics debacle
Pharmaceutical and biotech shares are suffering a massive blow from repercu...
by Nam Doo-hyun
|
2018-05-08 11:20
라인
Celltrion launches third biosimilar in EU
Celltrion Healthcare said Thursday that it has started marketing Herzuma (O...
by Lee Han-soo
|
2018-05-04 17:21
라인
Samsung BioLogics denies accounting irregularities
Shim Byung-hwa (left), Samsung BioLogics’ business innovation team leader, ...
by Lee Han-soo
|
2018-05-02 17:12
라인
VC investment in biomedicine rises 200% y-o-y in Q1
New venture capital investment in the biomedical industry rose more than 20...
by Nam Doo-hyun
|
2018-04-30 14:14
라인
Chong Kun Dang wins US patent for anemia biosimilar
Chong Kun Dang said Friday that it has acquired a patent regarding the form...
by Lee Han-soo
|
2018-04-27 15:39
라인
Hugel posts ₩45.8 billion in Q1 sales
Hugel said Tuesday that it recorded 45.8 billion won ($42.3 million) in the...
by Lee Han-soo
|
2018-04-26 12:51
라인
Samsung BioLogics posts ₩131 billion in Q1 sales
Samsung BioLogics said Tuesday that it recorded 131 billion won ($121.1 mil...
by Lee Han-soo
|
2018-04-25 17:47
라인
Pharma shares on the rise since early this year
Pharmaceutical and biotech shares have recently suffered declines, but most...
by Nam Doo-hyun
|
2018-04-25 13:56
라인
NIBEC wins anti-cancer peptide patent in the US
Nano Intelligence Biomedical Engineering Corporation (NIBEC) said Monday th...
by Lee Han-soo
|
2018-04-23 15:15
-
이전
21
22
23
24
25
26
27
28
-
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
여백
Most viewed
1
‘Cyramza helped improve gastric cancer treatment in Korea’
2
‘Reduced-dose prasugrel effective for ACS patients undergoing PCI’
3
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
4
SNUBH develops AI model predicting patients at risk of cerebral aneurysm
5
Novavax releases encouraging phase-1 results on Covid-19 vaccine candidate
6
LG Chem, SK Bioscience end sales partnership with Daewoong
7
UBcare wins patent for tech to monitor suspected infectious diseases
8
176 civic groups furious over government-doctors deal
9
Recovered Covid-19 patients suffer from aftereffects – for long
10
Regulator OKs JW Pharma's rheumarthritis drug for treating giant cell arteries
여백
Opinion
[Column] Correct diagnosis leads to proper treatment
[Column] How ongoing doctors’ strike is different from 20 years ago
A Korean-American Doctor asks: Is Korea truly in 2020?
여백
Back to Top